A study of an inherited BAP1 gene change and the cancers linked to it
Original title: Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed for this study, so it is still research.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study looks at an inherited gene change that can raise cancer risk.
Who this trial is for. This study is for people with cancer tied to an inherited change in the BAP1 gene. It also includes family members who may carry the same gene change.
Where it stands. This study has not reported results. It is looking at how often this gene change happens. It is also looking at which cancers come with it. Those cancers include melanoma, mesothelioma, kidney cancer, bile duct cancer, liver cancer, meningioma, and basal cell skin cancer. The answers are not in yet.
What this means, and what it doesn't
What it could mean: Nothing here changes care today. If these cancers run in your family, you could ask your care team about this study. They can help you decide if it fits you.
What it doesn't mean: This does not mean a new treatment is ready. A study is a test, not proven care. Joining one is not a promise that it will help you. It is also not a promise of a cure.
Source: ClinicalTrials.gov, October 16, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.